Alachua Government Services

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Alachua Government Services sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

Alachua Government Services: 12 sponsored US clinical trials, none currently recruiting.

Alachua Government Services sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. 4 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Traumatic Stress Disorder, with 1 trials.

Top-decile sponsor footprint

Alachua Government Services ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED NA

Evaluating Technologies for Point-of-Care Blood Collections by Patients

NCT06507566

COMPLETED Phase 1

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

NCT04592549

COMPLETED Phase 1

Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects

NCT04171115

COMPLETED Phase 1

Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults

NCT03046550

COMPLETED Phase 3

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

NCT01773928

COMPLETED NA

Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder

NCT01492699

COMPLETED Phase 1

Reverse Genetic H9N2 Influenza Vaccine Study in Adults

NCT01320696

COMPLETED Phase 1

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

NCT01258062

COMPLETED Phase 3

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

NCT00800605

COMPLETED Phase 3

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

NCT00782431

COMPLETED Phase 1

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

NCT00783926

COMPLETED Phase 3

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

NCT00566345

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 3 4

How the Alachua Government Services archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase mix: 4 late (III/IV) vs 6 early (I/II) (balanced across stages).

Top condition: Post Traumatic Stress Disorder (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Alachua Government Services: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Alachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsApnimed10xBio22nd Century Group23andMe3-C Institute for Social Development
Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Alachua Government Services page

12 registered trials is a research-attention snapshot, not an endorsement of Alachua Government Services or any single study.

  • None of Alachua Government Services's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Post Traumatic Stress Disorder is the condition Alachua Government Services studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Traumatic Stress Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alachua Government Services pipeline card: 12 registered trials from official public datasets.Report a data error.